Pulmonary Tuberculosis Clinical Trials

Find Pulmonary Tuberculosis Clinical Trials Near You

Effectiveness and Safety of Auricular Acupuncture for Nausea and Vomiting Side Effects Induced by Anti-Tuberculosis Drugs in Pulmonary TB Patients

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will look at whether press-needle ear acupuncture can help lower nausea and vomiting caused by antituberculosis medicines in people with pulmonary tuberculosis. Nausea and vomiting are common side effects of tuberculosis treatment, and they can make people stop taking their medicines When treatment is stopped too early, tuberculosis may not be cured and may become resistant to medicines. Participants in this study will have nausea and vomiting related to their tuberculosis treatment. They will be randomly assigned to one of two groups. One group will receive press-needle ear acupuncture. The other group will receive a placebo version that looks similar but does not stimulate acupuncture points Researchers will check nausea and vomiting scores before treatment, during treatment, and after treatment to see whether press-needle acupuncture works better than placebo and whether it is safe. Press-needle acupuncture may help reduce nausea and vomiting by affecting nerves and lowering certain chemicals that trigger these symptoms, and it has minimal side effects If this method is proven helpful and safe, it may give patients a comfortable and low-risk way to manage nausea and vomiting during tuberculosis treatment

Eligibility
Participation Requirements
Sex: All
Minimum Age: 17
Healthy Volunteers: f
View:

• Participants are individuals diagnosed with drug-sensitive tuberculosis or drug-resistant tuberculosis receiving short-term treatment regimens (BPaL/BPaLM)

• Participants are aged 17 years or older.

• Participants experience nausea and vomiting after taking antituberculosis drugs.

• Participants are willing to comply with the study schedule until completion and provide written informed consent.

Locations
Other Locations
Indonesia
RSUP Persahabatan
RECRUITING
Jakarta
Contact Information
Primary
Kevin Supratman, MD
kevin.supratman@ui.ac.id
08128080897
Backup
KEPK RSUPP
ethics@rsuppersahabatan.co.id
0214891708
Time Frame
Start Date: 2025-11-05
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 58
Treatments
Experimental: Press Needle Group
Press Needle
Sham_comparator: Sham Press Needle Group
Sham Press Needle
Related Therapeutic Areas
Sponsors
Leads: Indonesia University

This content was sourced from clinicaltrials.gov